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Figure S1. Full range FTIR spectra of the synthesized materials. 
 
Figure S2. Particle size distribution of Ru-modified nanoparticles in water (top) and culture medium (bottom). 
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Table S1. Variation of ruthenium and chloride concentrations from EDS measurement. 









MSN[Ru] 0.315 ± 0.25 0.08 ± 0.075 0.314 ± 0.10 0.187 ± 0.069 
MSN-H1[Ru] 8.361 ± 0.92 1.884 ± 0.25 7.287 ± 0.51 4.68 ± 0.45 
MSN-H2[Ru] 7.916 ± 0.92 1.706 ± 0.26 6.239 ± 0.59 3.85 ± 0.49 
 
Figure S3. EDS chromatograms of (a) MSN-H1[Ru]; (b) MSN-H2[Ru] and (c) MSN[Ru] with insets representing Ru 
mapping. 




Figure S4. UV/VIS spectra of supernatants at different pH values after 48 h of stirring. 
 
Figure S5. Viability of the B16F1 cells determined with CV and MTT assays treated (48 h) with pristine MSN on pH 5.0 
and 7.2. 
